瑞普利蒙生物

最新新闻

• BMO Capital Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $16
  \u5e02\u573a\u8d44\u8baf · 2026/6/30
• 评级变动
  Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 公司公告
  Frasers Property: REPL-General Announcement-Issue of S$150 Million Fixed Rate Notes Due 2036 By Frasers Property Treasury Pte. Ltd.
  SGX · 2026/8/28
• 评级变动
  Cantor Fitzgerald Upgrades Replimune(REPL.US) to Buy Rating
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 公司公告
  AdvancedSystems: REPL-General Announcement-COMMENCEMENT OF LEGAL PROCEEDINGS AGAINST ZICO CAPITAL PTE. LTD. AND APPLICATION FOR INJUNCTION
  SGX · 2026/7/23
• 评级变动
  Jefferies Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $24
  \u5e02\u573a\u8d44\u8baf · 2026/8/17
• 评级变动
  Wedbush Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $12
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 公司公告
  AdvancedSystems: REPL-General Announcement-COMMENCEMENT OF LEGAL PROCEEDINGS AGAINST ZICO CAPITAL PTE. LTD. AND APPLICATION FOR INJUNCTION
  SGX · 2026/7/23
• 评级变动
  Piper Sandler Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $14
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• 评级变动
  J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• J.P. Morgan Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $21
  \u5e02\u573a\u8d44\u8baf · 2026/8/26
• 评级变动
  BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $16
  \u5e02\u573a\u8d44\u8baf · 2026/7/31
• 评级变动
  Wedbush Downgrades Replimune(REPL.US) to Hold Rating, Cuts Target Price to $9
  \u5e02\u573a\u8d44\u8baf · 2026/7/28
• 评级变动
  Leerink Partners Initiates Replimune(REPL.US) With Buy Rating, Announces Target Price $17
  \u5e02\u573a\u8d44\u8baf · 2026/8/4
• 公司公告
  GuocoLand: REPL-General Announcement-ISSUANCE OF S$110M 2.50% NOTES DUE 2030 UNDER S$3B MMTN PROGRAMME OF GLL IHT PTE. LTD.
  SGX · 2026/6/30
• J.P. Morgan Upgrades Replimune(REPL.US) to Buy Rating, Raises Target Price to $17
  \u5e02\u573a\u8d44\u8baf · 2026/6/27
• 公司公告
  Sri Trang Gloves: REPL-General Announcement-Reporting Share Repurchase form for Financial Management Purposes No.2 (Revised Date)
  SGX · 2026/9/8
• BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Raises Target Price to $20
  \u5e02\u573a\u8d44\u8baf · 2026/8/7
• BMO Capital Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $20
  \u5e02\u573a\u8d44\u8baf · 2026/9/11
• 评级变动
  Wedbush Maintains Replimune(REPL.US) With Buy Rating, Maintains Target Price $19
  \u5e02\u573a\u8d44\u8baf · 2026/8/17

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。